The global Pharmaceutical Contract Research and Manufacturing (CRAM) market was valued at US$ 215450 million in 2022 and is projected to reach US$ 378280 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The field of contract research and manufacturing broadly encompasses those services in the pharmaceutical and biotechnology sectors that require extensive research and development and large-scale manufacturing facilities.
Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-pharmaceutical-contract-manufacturing-forecast-2023-2030-168
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Research and Manufacturing (CRAM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Research and Manufacturing (CRAM). This report contains market size and forecasts of Pharmaceutical Contract Research and Manufacturing (CRAM) in global, including the following market information:
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The drug development processes in emerging economies are witnessing significant healthcare infrastructure and technological advancements. This results in the outsourcing of research and manufacturing operations of various drugs from developed nations to the vendors in emerging countries. Moreover, the availability of cost-efficient resources in emerging countries is also one of the critical reasons for the growing popularity of outsourcing. Developing nations are most preferred for contract manufacturing organizations because of the presence of several US FDA-approved manufacturing plants. These factors will boost the growth of the global pharmaceutical contract research and manufacturing market during the forecast period.The advent of big data is gaining traction in the contract manufacturing industry trends. Several pharmaceutical contract research and manufacturing companies increasingly use big data, as drug development involves complex data handling. Moreover, the use of big data is effective for the identification of new potential drug candidates and the monitoring of side effects. The use of big data also helps avoid the high cost of adverse events. These advantages of big data encourage companies to enter the pharmaceutical contract manufacturing market.
We surveyed the Pharmaceutical Contract Research and Manufacturing (CRAM) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Segment Percentages, by Type, 2022 (%)
Contract Research Organizations (CRO)
Contract Manufacturing Organizations (CMO)
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Biotechnology
Other
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Contract Research and Manufacturing (CRAM) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmaceutical Contract Research and Manufacturing (CRAM) revenues share in global market, 2022 (%)
Key players include:
Boehringer Ingelheim International GmbH
Catalent, Inc
IQVIA
Lonza
Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Contract Research and Manufacturing (CRAM), market overview.
Chapter 2: Global Pharmaceutical Contract Research and Manufacturing (CRAM) market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical Contract Research and Manufacturing (CRAM) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Contract Research and Manufacturing (CRAM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-pharmaceutical-contract-manufacturing-forecast-2023-2030-168
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Comments